Home  /  Resource Library  /  Advances in CD30- and PD-1-targeted therapies for classical Hodgkin lymphoma

Advances in CD30- and PD-1-targeted therapies for classical Hodgkin lymphoma

Article discusses the developments of CD30 and PD-1 blockade therapies for Hodgkin lymphoma.